Convergent Microenvironment Linking Idiopathic Pulmonary Fibrosis and Lung Cancer
Expert Reviews in Molecular Medicine · 2026 · 28
DOI: 10.1017/erm.2026.10065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, online erschienen am 10.07.2026. Verfasst von Min Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, People's Republic of China. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Lung Neoplasms, Tumor Microenvironment, Cellular Microenvironment. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic Public Welfare Research Program of Zhejiang Province, Natural Science Foundation of Zhejiang Province, Huzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Background
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease with limited treatment options and a poor prognosis. Lung cancer (LC) is one of the most common comorbidities in IPF, and IPF is recognized as an independent risk factor for the development of LC. In recent years, increasing evidence has suggested that these two diseases may share convergent genetic, epigenetic and cellular mechanisms, particularly within their microenvironments.
Methods
A comprehensive literature search was performed across PubMed, Web of Science, and Google Scholar databases to identify relevant studies focusing on the shared cellular components, immune and stromal behaviors, and pathogenic pathways within the microenvironments of IPF and LC.
Results
This review delineates the convergent features of the IPF and LC microenvironments by synthesizing the functional reprogramming of key cellular constituents. The immunological landscape is characterized by aberrant macrophage polarization, T-cell exhaustion and the accumulation of immunosuppressive myeloid-derived suppressor cells and immature dendritic cells. Furthermore, profound stromal alterations are observed, encompassing fibroblast activation, pathological extracellular matrix remodelling, epithelial–mesenchymal transition and dysregulated angiogenesis. These common cellular and molecular alterations may simultaneously drive fibrosis progression and tumorigenesis.
Conclusions
A deeper understanding of the relationship between the IPF and LC microenvironments will help identify shared pathological mechanisms and provide new insights for developing more targeted diagnostic and therapeutic strategies for idiopathic pulmonary fibrosis associated with lung cancer (IPF-LC).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, People's Republic of China.
- Department of Respiratory Medicine, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, People's Republic of China.
- Department of Respiratory Medicine, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou Normal University, Huzhou, People's Republic of China.
ORCID-Profile: Xuefei Shi, Enhai Cui
Förderung
- Basic Public Welfare Research Program of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
- Huzhou Municipal Science and Technology Bureau
Zitieren
APA
Chen, M., Zhu, Y., Wang, B., Zhang, L., Chen, B., Shi, X., & Cui, E. (2026). Convergent Microenvironment Linking Idiopathic Pulmonary Fibrosis and Lung Cancer. Expert Reviews in Molecular Medicine, 28. https://doi.org/10.1017/erm.2026.10065
Vancouver
Chen M, Zhu Y, Wang B, Zhang L, Chen B, Shi X, et al. Convergent Microenvironment Linking Idiopathic Pulmonary Fibrosis and Lung Cancer. Expert Reviews in Molecular Medicine. 2026;28. doi:10.1017/erm.2026.10065
BibTeX
@article{Chen2026,
author = {Chen, Min and Zhu, Yeyuan and Wang, Bin and Zhang, Lijuan and Chen, Boyi and Shi, Xuefei and Cui, Enhai},
title = {Convergent Microenvironment Linking Idiopathic Pulmonary Fibrosis and Lung Cancer},
journal = {Expert Reviews in Molecular Medicine},
year = {2026},
volume = {28},
doi = {10.1017/erm.2026.10065}
}
EUVIMED